21. Mitochondrial disease Clinical trials / Disease details
Clinical trials : 39 / Drugs : 42 - (DrugBank : 32) / Drug target genes : 47 - Drug target pathways : 67
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02053766 (ClinicalTrials.gov) | January 10, 2014 | 31/1/2014 | Anesthesia in Patients With Mitochondrial Disease | Anesthesia in Patients With Mitochondrial Disease | Mitochondrial Diseases | Drug: Sevoflurane;Drug: Dexmedetomidine;Drug: Propofol | The University of Texas Health Science Center, Houston | NULL | Recruiting | N/A | 17 Years | All | 60 | N/A | United States |
2 | NCT01001585 (ClinicalTrials.gov) | September 2006 | 21/10/2009 | Anesthetic Effects in Mitochondrial Disease | Anesthetic Effects in Mitochondrial Disease | Mitochondrial Disease | Drug: sevoflurane | d sessler | NULL | Terminated | 12 Months | 16 Years | Both | 55 | N/A | United States |